{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:45:16Z","timestamp":1747169116350,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.pharma.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:18:15Z","timestamp":1722266295000},"page":"1118-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost analysis study comparing the impact of treatment with aprotinin versus tranexamic acid in cardiac surgery under cardiopulmonary bypass"],"prefix":"10.1016","volume":"82","author":[{"given":"Cl\u00e9mence","family":"Huynh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Crubezy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian","family":"Trin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Perino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanta","family":"Ramaroson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Puntous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloise","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-196X","authenticated-orcid":false,"given":"Fabien","family":"Xuereb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharma.2024.07.005_bib0100","first-page":"CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"2011","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pharma.2024.07.005_bib0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharma.2024.07.005_bib0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1537-2995.2006.00724.x","article-title":"A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery","volume":"46","author":"Karkouti","year":"2006","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0115","doi-asserted-by":"crossref","first-page":"ezae001","DOI":"10.1093\/ejcts\/ezae001","article-title":"Use of Aprotinin versus Tranexamic Acid in Cardiac Surgery Patients with High-Risk for Excessive Bleeding (APACHE) trial: a multicentre retrospective comparative non-randomized historical study","volume":"65","author":"Gallo","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"issue":"22","key":"10.1016\/j.pharma.2024.07.005_bib0120","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2024.07.005_bib0125","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit [Internet]. Base de donn\u00e9es publique du m\u00e9dicament. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=65436166&typedoc=R. [Consulted on November 2, 2023 (1 pp.)]."},{"key":"10.1016\/j.pharma.2024.07.005_bib0130","unstructured":"Association Anesth\u00e9rie-R\u00e9animation Coeur-Thorax-Vaisseaux. ARCOTHOVA [Internet]. https:\/\/arcothova.com\/wp-content\/uploads\/2019\/01\/Reco-aprotinine-ARCOTHOVA.pdf [Consulted on November 2, 2023 (1 pp.)]."},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1503\/cmaj.081109","article-title":"The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis","volume":"180","author":"Henry","year":"2009","journal-title":"CMAJ"},{"issue":"22","key":"10.1016\/j.pharma.2024.07.005_bib0140","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2024.07.005_bib0145","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1959-0318(10)70004-X","article-title":"Nature du priming de la circulation extracorporelle en chirurgie cardiaque adulte et p\u00e9diatrique","volume":"31","author":"Rozec","year":"2010","journal-title":"IRBM"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0150","first-page":"141","article-title":"Uncertainty and the welfare economics of medical care. 1963","volume":"82","author":"Arrow","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.pharma.2024.07.005_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001886.pub2","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharma.2024.07.005_bib0160","unstructured":"AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding (APACHE), ClinicalTrials.gov ID NCT04804345, Sponsor University Hospital, Bordeaux, Information provided by University Hospital, Bordeaux (Responsible Party), Last Update Posted 2022-03-03, https:\/\/clinicaltrials.gov\/study\/NCT04804345. [Consulted on November 2, 2023 (1 pp.)]."},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0165","doi-asserted-by":"crossref","first-page":"ezae038","DOI":"10.1093\/ejcts\/ezae038","article-title":"Retrospective aprotinin cardiac surgical studies and their limitations: time for a prospective randomized clinical trial","volume":"65","author":"Erdoes","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.athoracsur.2003.06.008","article-title":"Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials","volume":"77","author":"Smith","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.005_bib0175","doi-asserted-by":"crossref","first-page":"s21","DOI":"10.1016\/0003-4975(95)01079-3","article-title":"Cost\/benefit analysis of pharmacologic hemostasis","volume":"61","author":"Harmon","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.005_bib0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.accpm.2020.10.012","article-title":"French legal approach to patient consent in clinical research","volume":"39","author":"Toulouse","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"4","key":"10.1016\/j.pharma.2024.07.005_bib0185","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s12325-023-02464-7","article-title":"Cost analysis of aprotinin reintroduction in French Cardiac Surgery Centres: a real-world data-based analysis","volume":"40","author":"Colson","year":"2023","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.005_bib0190","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0003-4975(96)00451-1","article-title":"Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens","volume":"62","author":"Lemmer","year":"1996","journal-title":"Ann Thorac Surg"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T17:48:23Z","timestamp":1729705703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0003450924001044"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.07.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost analysis study comparing the impact of treatment with aprotinin versus tranexamic acid in cardiac surgery under cardiopulmonary bypass","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}